Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role Of Combined Therapy With Aspirin and Enoxaparin In Prevention Of Venous Thromboembolism In Trauma Patients: A Randomized-Controlled Trial

NCT02396732 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT02396732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02396732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role Of Combined Therapy With Aspirin and Enoxaparin In Prevention Of Venous Thromboembolism In Trauma Patients: A Randomized-Controlled Trial
Lead sponsor
University of Miami
Phase
Phase 4
Overall status
Terminated
Start date
February 29, 2016
Completion date
May 15, 2018
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thromboprophylaxis, trauma, venous thromboembolism